STUDY ON THE RELATIONSHIP BETWEEN VITAMIN D STATUS AND MYOCARDIAL INFARCTION RISK
Main Article Content
Keywords
Vitamin D deficiency, 25-hydroxyvitamin D, myocardial infarction, cardiovascular disease, risk factors, prospective study
Abstract
Background: Vitamin D deficiency has emerged as a potential modifiable risk factor for cardiovascular disease. However, the specific relationship between vitamin D status and myocardial infarction risk remains incompletely understood.
Methods: This prospective study enrolled 356 participants aged 45-75 years without prior myocardial infarction, followed for 24 months. Participants were categorized into three groups based on baseline serum 25(OH)D levels: deficient (<20 ng/mL, n=128), insufficient (20-29 ng/mL, n=142), and sufficient (≥30 ng/mL, n=86). Primary outcome was incident myocardial infarction. Secondary outcomes included major adverse cardiovascular events and all-cause mortality. Serum 25(OH)D, lipid profiles, inflammatory markers, and cardiovascular risk factors were assessed.
Results: Mean baseline serum 25(OH)D levels were 15.8 ± 3.4 ng/mL, 24.6 ± 2.8 ng/mL, and 36.2 ± 5.4 ng/mL in the deficient, insufficient, and sufficient groups, respectively. During follow-up, myocardial infarction occurred in 24.2% of vitamin D deficient participants, 12.7% in insufficient, and 4.7% in sufficient groups (p<0.001). After adjusting for traditional cardiovascular risk factors, vitamin D deficiency was independently associated with increased myocardial infarction risk (hazard ratio 4.18, 95% CI: 1.86-9.42, p=0.001). High-sensitivity C-reactive protein levels were significantly elevated in the deficient group (4.8 ± 2.2 mg/L vs. 2.1 ± 1.4 mg/L, p<0.001).
Conclusion: Vitamin D deficiency is independently associated with significantly increased myocardial infarction risk. These findings suggest that vitamin D status assessment and optimization may represent important strategies for cardiovascular disease prevention.
References
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52. PMID: 15364185
3. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81. PMID: 17634462
4. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-38. PMID: 12122115
5. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353-73. PMID: 16529140
6. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174-80. PMID: 18541825
7. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503-11. PMID: 18180395
8. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167(16):1730-7. PMID: 17846391
9. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005;94(4):483-92. PMID: 16197570
10. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2813-8. PMID: 15562190
11. Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO, et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke. 2008;39(9):2611-3. PMID: 18635847
12. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340-9. PMID: 18574092
13. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med. 2007;167(11):1159-65. PMID: 17563024
14. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754-9. PMID: 16600924
15. Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990;19(3):559-63. PMID: 2262248
							